News | July 30, 2025
Torrent Pharmaceuticals posts Q1 FY26 consolidated PAT higher at Rs. 548 Cr
Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025
Torrent Pharmaceuticals has reported total income of Rs. 3,141 crores during the period ended June 30, 2025
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
Torrent Pharmaceuticals has reported total income of Rs. 2,842 crores during the period ended December 31, 2024
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Torrent Pharmaceuticals has reported total income of Rs. 2,883 crores during the period ended June 30, 2024
There was no observation related to data integrity reported
Laurus Synthesis receives Form 483 with 5 observations from USFDA
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
